Burkina Faso vs Puerto Rico: Tuberculosis treatment success rate by type
Burkina Faso
81
in 2023
Puerto Rico
81
in 2022
Burkina Faso rank
115th
Puerto Rico rank
115th
Tuberculosis treatment success rate by type over time
- Burkina Faso
- Puerto Rico
How they compare
Burkina Faso currently reports 81 against 81 in Puerto Rico, a difference of 0.
The two have swapped places 9 times across 28 shared years of data; in 1995 it was Puerto Rico ahead.
Burkina Faso ranks 115th and Puerto Rico ranks 115th of 194 countries.
Across the 4 decades both report, Burkina Faso averaged higher in 2 and Puerto Rico in 2.
Head to head by decade
| Decade | Burkina Faso | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 47 | 69.6 | 22.6 | Puerto Rico |
| 2000s | 69.1 | 71.6 | 2.5 | Puerto Rico |
| 2010s | 79.5 | 72.5 | 7 | Burkina Faso |
| 2020s | 82 | 79 | 3 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Burkina Faso or Puerto Rico?
- Burkina Faso, at 81 against 81 in Puerto Rico as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Burkina Faso and Puerto Rico?
- 0, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Puerto Rico?
- 28 years are reported by both, from 1995 to 2022.
- How do Burkina Faso and Puerto Rico rank globally for tuberculosis treatment success rate by type?
- Burkina Faso ranks 115th and Puerto Rico ranks 115th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.